DexCom
DXCM
$124.34
Share price
-9.91%
Change (1 day)
0.61%
Change (1 year)
Categories
DexCom (DXCM) - Cash on Hand
Cash on Hand as of December 2023 : $2.72 B
According to DexCom's latest financial reports the company has $2.72 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
DexCom - Cash on Hand chart (from 2005 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $2.72 B | 10.91% |
| 2022-12-31 | $2.45 B | -10.07% |
| 2021-12-31 | $2.73 B | 0.87% |
| 2020-12-31 | $2.70 B | 76.59% |
| 2019-12-31 | $1.53 B | 10.66% |
| 2018-12-31 | $1.38 B | 152.57% |
| 2017-12-31 | $0.54 B | 343.49% |
| 2016-12-31 | $0.12 B | 7.38% |
| 2015-12-31 | $0.11 B | 37.8% |
| 2014-12-31 | $83.6 M | 53.11% |
| 2013-12-31 | $54.6 M | 12.11% |
| 2012-12-31 | $48.7 M | -40.61% |
| 2011-12-31 | $82 M | 74.05% |
| 2010-12-31 | $47.11 M | 68.16% |
| 2009-12-31 | $28.01 M | 3.5% |
| 2008-12-31 | $27.06 M | -57.92% |
| 2007-12-31 | $64.32 M | 18.01% |
| 2006-12-31 | $54.5 M | 7.88% |
| 2005-12-31 | $50.52 M | 85.55% |
| 2004-12-31 | $27.22 M | 36.04% |
| 2003-12-31 | $20.01 M | |
| 2001-12-31 | $7.77 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 741.64% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 167.21% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 205.46% | 🇮🇪 Ireland |
 Becton Dickinson BDX | $1.18 B | -56.61% | 🇺🇸 USA |
 Edwards Lifesciences EW | $1.64 B | -39.63% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.46 B | -82.82% | 🇺🇸 USA |
 QuidelOrtho QDEL | $0.16 B | -93.86% | 🇺🇸 USA |
 West Pharmaceutical WST | $0.85 B | -68.65% | 🇺🇸 USA |